Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Neoleukin Therapeutics In...

    NASDAQ: NLTX · Real-Time Price · USD
    3.49
    0.05 (1.45%)
    At close: Dec 18, 2023, 10:00 PM

    Neoleukin Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 6K
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a 6K
    Operating Income
    		 -82.61M -59.1M -60.7M
    Interest Income
    		 8.47M 1.58M 19K
    Pretax Income
    		 -75.14M -57.56M -60.69M
    Net Income
    		 -75.14M -57.56M -60.69M
    Selling & General & Admin
    		 22.61M 17.97M 21.54M
    Research & Development
    		 60.92M 41.13M 39.16M
    Other Expenses
    		 n/a -42K 6K
    Operating Expenses
    		 83.53M 59.1M 60.7M
    Interest Expense
    		 -12K 1.58M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 n/a 59.1M 60.7M
    Income Tax Expense
    		 n/a -1.54M -2.28M
    Shares Outstanding (Basic)
    		 18.98M 11.04M 11.01M
    Shares Outstanding (Diluted)
    		 18.98M 11.04M 11.01M
    EPS (Basic)
    		 -3.96 -5.07 -5.31
    EPS (Diluted)
    		 -3.96 -5.07 -5.5
    EBITDA
    		 -82.61M -56.48M -60.7M
    EBIT
    		 n/a -55.98M n/a
    Depreciation & Amortization
    		 n/a 2.61M 2.28M

    Add to Watchlist